Bovine Mesenteric Venous Graft as an Alternative Conduit in Patients with Cyanotic Heart Disease with E-Polytetrafluoroethylene Graft Failure Caused by Thrombophilic Factor Positivity after Modified Blalock-Taussig Shunt

2008 ◽  
Vol 11 (1) ◽  
pp. E37-E41
Author(s):  
B. Akbulut ◽  
Omer Faruk Dogan ◽  
M. Guvener ◽  
M. Yilmaz ◽  
C. Yorgancioglu ◽  
...  
Keyword(s):  
Heart Disease ◽  
Graft Failure ◽  
Cyanotic Heart Disease ◽  
Venous Graft ◽  
Blalock Taussig Shunt

Patency and development of stenosis in modified Blalock-Taussig shunts constructed using expanded polytetrafluoroethylene

1997 ◽  
Vol 7 (2) ◽  
pp. 153-159
Author(s):  
François Godart ◽  
Shakeel A. Qureshi ◽  
Ary Simha ◽  
Nuala Fagg ◽  
Philip B. Deverall ◽  
...  
Keyword(s):  
Regression Analysis ◽  
Heart Disease ◽  
Patency Rate ◽  
Cyanotic Heart Disease ◽  
Progressive Reduction ◽  
Expanded Polytetrafluoroethylene ◽  
Blalock Taussig Shunt

AbstractConstruction of a modified Blalock-Taussig shunt using polytetrafluroethylene is frequently used for palliation in infants with complex cyanotic heart disease. This study was performed to assess angiographically the late patency rate of such prosthetic shunts. A modified Blalock-Taussig shunt had been constructed in 82 children and, of these, 63 (77%) patients had post-operative angiography and were included in this study. There were 29 males and 34 females, ranging in age from 1 day to 164 months. A second shunt was needed in 7 patients. Thus, 70 shunts were studied. Of the shunts, 16 were 4 mm in diameter, 28 shunts 5 mm in diameter, and 26 shunts 6 mm in diameter. Postoperative angiography was performed on 1 day to 132 months (median 39 months) after construction of the shunts. Acute post operative occlusion occurred in 2(3%) patients, who had 5 and 6 mm shunts, respectively. At the latest follow-up (median 39 ± 26 months), 6(9%) late occlusions were noticed. Overall patency was 89% for all the shunts, with 94% of the 4 mm shunts, 85% of the 5 mm and 88% of the 6 mm shunts being patent. Regression analysis showed a progressive reduction in diameter of the graft with time. This narrowing of the graft may have been related to the formation of a ‘neointima’ due to fibrous hyperplasia.

scholarly journals Perigraft seroma following Right Modified Blalock Taussig shunt in a child with complex cyanotic heart disease

2013 ◽  
Vol 18 (2) ◽  
pp. 25
Author(s):  
DCL De Silva ◽  
SN Perera ◽  
I Wijemanne ◽  
LAP Perera ◽  
R Mahalekamge ◽  
...  
Keyword(s):  
Heart Disease ◽  
Cyanotic Heart Disease ◽  
Perigraft Seroma ◽  
Blalock Taussig Shunt

scholarly journals BILATERAL PHEOCHROMOCYTOMAS IN CYANOTIC HEART DISEASE AFTER FONTAN PALLIATION

2021 ◽  
Vol 77 (18) ◽  
pp. 2975
Author(s):  
Amanda Meredith ◽  
Giselle Suero-Abreu ◽  
Renjit Thomas
Keyword(s):  
Heart Disease ◽  
Cyanotic Heart Disease ◽  
Fontan Palliation

Intranasal dexmedetomidine: the ideal drug for sedation in the pediatric echo lab?

2021 ◽  
pp. 1-5
Author(s):  
David E Saudek ◽  
Deborah Walbergh ◽  
Peter Bartz ◽  
Sara Shreve ◽  
Amy Schaal ◽  
...  
Keyword(s):  
Heart Rate ◽  
Heart Disease ◽  
Chart Review ◽  
Chloral Hydrate ◽  
Vital Signs ◽  
Cyanotic Heart Disease ◽  
Historical Cohort ◽  
Safety And Efficacy ◽  
Attractive Option ◽  
The Ideal

Abstract Background: Intranasal dexmedetomidine is an attractive option for procedural sedation in pediatrics due to ease of administration and its relatively short half-life. This study sought to compare the safety and efficacy of intranasal dexmedetomidine to a historical cohort of pediatric patients sedated using chloral hydrate in a pediatric echo lab. Methods: Chart review was performed to compare patients sedated between September, 2017 and October, 2019 using chloral hydrate and intranasal dexmedetomidine. Vital signs, time to sedation, duration of sedation, need for second dose of medication, rate of failed sedation, and impact on vital signs were compared between groups. Subgroup analysis was performed for those with complex and cyanotic heart disease. Results: Chloral hydrate was used in 356 patients and intranasal dexmedetomidine in 376. Patient age, complexity of heart disease, and duration of sedation were similar. Rates of failed sedation were very low and similar. Average heart rate and minimum heart rate were lower for those receiving intranasal dexmedetomidine than chloral hydrate. Impact on vital signs was similar for those with complex and cyanotic heart disease. No adverse events occurred in either group. Conclusions: Sedation with intranasal dexmedetomidine is comparable to chloral hydrate in regards to safety and efficacy for children requiring echocardiography. Consistent with the mechanism of action, patients receiving intranasal dexmedetomidine have a lower heart rate without morbidity.

Cyanosis and Clipping: Noninfectious Aneurysm in a Patient with 22q11.2 Deletion Syndrome

2021 ◽  
pp. 1-5
Author(s):  
Bhanu Jayanand Sudhir ◽  
Sanjay Honavalli Murali ◽  
Jaypalsinh Gohil ◽  
Rajalakshmi Poyuran ◽  
Manikantan Sethuraman ◽  
...  
Keyword(s):  
Heart Disease ◽  
Cerebral Aneurysms ◽  
Artery Aneurysm ◽  
22Q11.2 Deletion Syndrome ◽  
Neurological Deficits ◽  
Deletion Syndrome ◽  
Anterior Communicating Artery ◽  
Cyanotic Heart Disease ◽  
22Q11.2 Deletion ◽  
Congenital Cyanotic Heart Disease

Noninfectious cerebral aneurysms are rare in patients with congenital cyanotic heart disease. We present a patient with DiGeorge/velocardiofacial syndrome with a complex congenital cyanotic heart disease with a ruptured anterior communicating artery aneurysm. The 10-year-old child was managed by surgical clipping of the aneurysm. Surgical challenges included prominent veins in the Sylvian fissure, difficulty in differentiating arterial and venous bleed, and anesthetic risks. The patient recovered without any neurological deficits. This is the first report of a patient with 22q11.2 deletion syndrome, with a noninfectious cerebral aneurysm.

scholarly journals 15O-water PET for evaluation of cardiopulmonary perfusion in complex cyanotic heart disease

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
S. Madsen ◽  
L. P. Tolbod ◽  
U. M. Mortensen ◽  
G. Andersen ◽  
K. Bouchelouche
Keyword(s):  
Heart Disease ◽  
Cyanotic Heart Disease

Selective coronary angiography via antegrade venous route in congenital cyanotic heart disease

1993 ◽  
Vol 28 (2) ◽  
pp. 179-182 ◽  
Author(s):  
Yunus S. Loya ◽  
Robin J. Pinto ◽  
Dhruman M. Desai ◽  
Usha Sundaram ◽  
Ajit R. Bhagwat ◽  
...  
Keyword(s):  
Heart Disease ◽  
Coronary Angiography ◽  
Cyanotic Heart Disease ◽  
Selective Coronary Angiography ◽  
Congenital Cyanotic Heart Disease

Determinants of platelet count in pediatric patients with congenital cyanotic heart disease: Role of immature platelet fraction

2017 ◽  
Vol 13 (1) ◽  
pp. 118-123 ◽  
Author(s):  
Randa M. Matter ◽  
Iman A. Ragab ◽  
Alaa M. Roushdy ◽  
Ahmed G. Ahmed ◽  
Hanan H. Aly ◽  
...  
Keyword(s):  
Platelet Count ◽  
Heart Disease ◽  
Pediatric Patients ◽  
Cyanotic Heart Disease ◽  
Immature Platelet Fraction ◽  
Congenital Cyanotic Heart Disease

Fifteen-minute consultation: Assessing the child with a Blalock-Taussig shunt who is unwell in a district general hospital

2019 ◽  
Vol 105 (3) ◽  
pp. 142-146 ◽  
Author(s):  
Steven McVea ◽  
Anne McGettrick
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
General Hospital ◽  
Congenital Heart ◽  
District General Hospital ◽  
Univentricular Heart ◽  
Pulmonary Shunt ◽  
Intercurrent Illness ◽  
General Paediatrician ◽  
Blalock Taussig Shunt

Univentricular heart disease accounts for ~1.25% of all congenital heart disease. Such cases remain among the most challenging to manage, typically requiring a three-staged palliation. The first stage involves placement of a systemic to pulmonary shunt. While a variety of shunt types, including ductal stenting, can be used to manage univentricular conditions, the archetype remains the Blalock-Taussig (BT) shunt. While waiting future palliative intervention at home, intercurrent illness may necessitate presentation to a district general hospital where subspecialist advice and assessment is remote. This review aims to present the general paediatrician with a straightforward BT shunt physiology overview highlighting unique complications which may complicate intercurrent illness.

Sign in / Sign up

Export Citation Format

Share Document